Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.3%

1 terminated/withdrawn out of 30 trials

Success Rate

95.8%

+9.3% vs industry average

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

13%

3 of 23 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
9(81.8%)
Phase 4
1(9.1%)
Phase 1
1(9.1%)
11Total
N/A(9)
Phase 4(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (30)

Showing 20 of 30 trials
NCT07560046Phase 4Not Yet Recruiting

Combating Related Epidemics in HCV

Role: collaborator

NCT04793750Not ApplicableCompleted

Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC)

Role: collaborator

NCT07520279Enrolling By Invitation

Xpert® Tropical Fever Test on GeneXpert® Edge X System

Role: lead

NCT06438575Not ApplicableCompleted

Point of Care Diagnosis of Vaginal Infections

Role: collaborator

NCT07489846Completed

Xpert® ERP on the GeneXpert® System

Role: lead

NCT06281691Completed

GreenBladder - Early Detection of Bladder Cancer in Residents in Greenland Using a Urinary Marker and a Mobile Cystoscopy Unit

Role: collaborator

NCT07370454Completed

Xpert® Hemorrhagic Fever on the GeneXpert® Edge X System

Role: lead

NCT07307300Not Yet Recruiting

Study on Risk Assessment for Patients With Microscopic Hematuria (Non-Visible Blood in Urine) Using a Urine Marker Test

Role: collaborator

NCT03767231Not ApplicableNot Yet Recruiting

ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing

Role: collaborator

NCT04878328Not ApplicableCompleted

Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO

Role: collaborator

NCT06508996Completed

Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System

Role: lead

NCT02922816Phase 1Terminated

FMT for MDRO Colonization After Infection in Renal Transplant Recipients

Role: collaborator

NCT04100733Not ApplicableActive Not Recruiting

Surveillance of High-grade Non-muscle Invasive Bladder Tumours Using the Xpert Bladder Cancer Monitor

Role: collaborator

NCT04610762Completed

HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels

Role: collaborator

NCT03734172Completed

Rapid and Accurate Diagnosis of Paediatric TB (RaPaed-AIDA-TB)

Role: collaborator

NCT03664258Completed

A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X)

Role: lead

NCT02755402Not ApplicableCompleted

Accelerated Pre-treatment Evaluation for HCV Infected Persons Who Inject Drugs

Role: collaborator

NCT03728725Completed

Xpert MTB/XDR Clinical Evaluation Trial

Role: collaborator

NCT04647981Completed

Diagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test.

Role: collaborator

NCT03936816Completed

The Implementation of Real-time PCR - Intrapartum GBS (Group B Streptococcus) Colonization to Reduce Antibiotic Prophylaxis

Role: collaborator